Urology News and Research

Latest Urology News and Research

New Penn Medicine study raises questions about NLR as biomarker for bladder cancer

A blood test that has shown promise in predicting how cancer will progress and what treatments will be most effective for a given patient may not be reliable for either, according to a new Penn Medicine study published this week in Cancer, a peer-reviewed journal of the American Cancer Society.

27 Oct 2016

Scientists uncover new class of small molecules for fighting urinary tract infection

This spring, a Pennsylvania woman who developed a urinary tract infection (UTI) became the first patient in the U.S. reported to have a bacterial infection resistant to colistin, an antibiotic of last resort.

26 Oct 2016

Reducing contamination rates in urine samples: an interview with Prof. Frank Chinegwundoh MBE

Contamination is thought to be a significant problem. Depending on which study you look at, the rates of urine contamination can be 17% or upwards. The standard method of midstream urine collection is for the healthcare professional...

26 Oct 2016

Basal tumor cell marker could help physicians personalize care for patients with bladder cancer

Tumor cells collected during the removal of a cancerous bladder and - in some cases - transplanted into mice with weakened immune systems, could help physicians rapidly identify high-risk cancers, determine prognosis and refine the use of biomarkers to personalize care for patients with this common cancer, according to a study published online on Oct. 24, 2016, in Scientific Reports.

24 Oct 2016

Study reveals promising new strategy to treat birth defect in boys

A study published in Scientific Reports describes a potential new strategy that may be utilized to correct hypospadias, a birth defect which occurs when boys are born with a urinary opening on the underside of the penis, found in up to one in every 200 boys.

21 Oct 2016

Einstein researchers awarded $2.6 million NIH grant to develop effective cancer immunotherapies

The National Institutes of Health has awarded two co-investigators at Albert Einstein College of Medicine a five-year, $2.6 million grant to make immunotherapy agents that more precisely and effectively treat a variety of cancers while causing far fewer side effects than current immunotherapies.

20 Oct 2016

Cost-effective modified natural cycle IVF offers hope to young couples with fewer financial resources

Researchers at University of Southern California (USC) Fertility at Keck Medicine of USC have determined that modified natural cycle in-vitro fertilization (IVF) is a more cost-effective fertility method than controlled ovarian stimulation and traditional IVF.

19 Oct 2016

New magnetic surgical device to be displayed in Texas for British Medtech mission

A pioneering magnetic surgical device that eliminates exposure to radioactive materials and offers a less invasive, more flexible alternative for breast cancer surgery will be showcased in Texas next week (15th – 21st October 2016)as part of a British Medtech mission.

19 Oct 2016

Chemotherapy leads to drug-resistance in bladder cancer patients

Chemotherapy is indicated as the first line of treatment for advanced bladder cancer. New research by Weill Cornell Medicine and University of Trento scientists shows that while chemotherapy kills the most common type of bladder cancer, urothelial cancer, chemotherapy also shapes the genetic evolution of remaining urothelial cancer cell clones to become drug-resistant.

18 Oct 2016

New OU photothermal therapy may eliminate tumors without affecting healthy cells in the body

A staggering 1.7 million persons in the United States will be diagnosed with cancer in 2016, with 600,000 cases ending in death. University of Oklahoma researchers have collaborated to design a novel, non-invasive cancer therapy that could eliminate tumors without affecting the healthy cells in the body.

18 Oct 2016

Cold medication could suppress spread of bladder cancers

Hokkaido University researchers have discovered that a nonsteroid anti-inflammatory drug used for treating colds suppresses the spread of bladder cancers and reduces their chemoresistance in mice, raising hopes of a future cure for advanced bladder cancers.

17 Oct 2016

Six million investment to boost research on new antibiotics

Edith Schippers, Minister of Health, will be investing six million euros over the coming four years to boost research on new antibiotics. The programme will be set up by several different parties, including the Leiden Centre for Antimicrobial Research.

13 Oct 2016

Study of pan-FGFR inhibitor uses mRNA in tumours to identify responders

The first-in-human dose escalation study of the pan-FGFR (fibroblast growth factor receptor) inhibitor BAY 1163877 in patients with treatment-refractory locally advanced or metastatic solid tumours were reported today at the ESMO 2016 Congress in Copenhagen.

8 Oct 2016

Immunotherapy redefines treatment approach for metastatic bladder cancer patients

Immunotherapy has shown promising results in first and second line treatment of metastatic bladder cancer in two phase II trials presented at the ESMO 2016 Congress in Copenhagen.

8 Oct 2016

Kessler Foundation receives Spinal Cord Injury Model System Grant from NIDILRR

Kessler Foundation has been awarded a Spinal Cord Injury Model System grant valued at $2,300,000 over 5 years (2016-2021) from the National Institute on Disability, Independent Living, and Rehabilitation Research.

7 Oct 2016

Research finds disparity in rates of prostate cancer treatment among African-American, Hispanic men

African-American and Hispanic men in the United States are less likely to receive therapy for prostate cancer compared to Caucasian men — even when they have more aggressive disease, according to new research from Roswell Park Cancer Institute and Vanderbilt University Medical Center.

7 Oct 2016

Researchers to explore potential roles of tumor-suppressor gene in kidney cancer

Renal cell carcinoma is the most common type of kidney cancer, and African-Americans and males appear most at risk for this disease that can be asymptomatic until it has spread and become highly lethal, said Dr. Vinata B. Lokeshwar, cancer researcher and chair of the Department of Biochemistry and Molecular Biology at the Medical College of Georgia at Augusta University.

7 Oct 2016

Revised prostate cancer guidelines did not reduce usage of PSA tests, study finds

Controversy over prostate cancer screening guidelines that discourage use of PSA tests did not significantly reduce use of the test, a five-year review of more than 275,000 visits at UT Southwestern Medical Center showed.

6 Oct 2016

C-11 choline PET and MRI help physicians map patterns of prostate cancer recurrence after surgery

A team of Mayo Clinic researchers has, for the first time, successfully mapped patterns of prostate cancer recurrence, following surgery. Using C-11 choline PET imaging and multiparametric MRI, researchers found an anatomically diverse pattern of recurrence, which may help optimize treatment of patients whose prostate cancer returns after surgery.

6 Oct 2016

Researchers identify new strategy to selectively sensitize cancer cells to radiation therapy

Many types of cancer become drug resistant, making them difficult to treat. Researchers with University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy to selectively sensitize certain cancer cells to radiation therapy that may improve tumor control and reduce treatment-related side effects.

5 Oct 2016

Urology News and Research

Latest Urology News and Research

New Penn Medicine study raises questions about NLR as biomarker for bladder cancer

Scientists uncover new class of small molecules for fighting urinary tract infection

Reducing contamination rates in urine samples: an interview with Prof. Frank Chinegwundoh MBE

Basal tumor cell marker could help physicians personalize care for patients with bladder cancer

Study reveals promising new strategy to treat birth defect in boys

Einstein researchers awarded $2.6 million NIH grant to develop effective cancer immunotherapies

Cost-effective modified natural cycle IVF offers hope to young couples with fewer financial resources

New magnetic surgical device to be displayed in Texas for British Medtech mission

Chemotherapy leads to drug-resistance in bladder cancer patients

New OU photothermal therapy may eliminate tumors without affecting healthy cells in the body

Cold medication could suppress spread of bladder cancers

Six million investment to boost research on new antibiotics

Study of pan-FGFR inhibitor uses mRNA in tumours to identify responders

Immunotherapy redefines treatment approach for metastatic bladder cancer patients

Kessler Foundation receives Spinal Cord Injury Model System Grant from NIDILRR

Research finds disparity in rates of prostate cancer treatment among African-American, Hispanic men

Researchers to explore potential roles of tumor-suppressor gene in kidney cancer

Revised prostate cancer guidelines did not reduce usage of PSA tests, study finds

C-11 choline PET and MRI help physicians map patterns of prostate cancer recurrence after surgery

Researchers identify new strategy to selectively sensitize cancer cells to radiation therapy

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Urology News and Research

Latest Urology News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in